METRONOMIA Clinical Research will be attending the ESMO Congress 2024 in Barcelona, where global leaders in oncology will gather to discuss the latest advancements in cancer research, treatment, and patient care.

With a proven track record of more than 175 oncology studies from preclinical to post-approval, Oncology is amongst the major indications at METRONOMIA: We successfully support innovative cancer therapies by taking care of all clinical data-related challenges, including biostatistical services and consulting, clinical data management, and medical writing.

Our ESMO team, Marcel Polak (mpolak@metronomia.net) and Lester Powell (lpowell@metronomia.net), is excited to connect with the oncology community and continue advancing cancer treatment!

Read more about the event: https://www.esmo.org/meeting-calendar/esmo-congress-2024